P R AG UE 2 0 1 5 Dear Colleague, On behalf of the NATA board of directors, it is my pleasure to invite you to the 16th NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis that will take place on April 16-17, 2015 in Prague, Czech Republic. Whether you participated or not in the first NATA symposium in Prague—10 years ago, already!—no doubt we will all enjoy (re)discovering this historical and architectural jewel of Central Europe. Every year NATA attracts a wide international and multidisciplinary audience, allowing delegates to share their experiences and network with a variety of specialists in their respective fields of interest. In line with our new mission statement—Promoting optimal patient blood management, haemostasis and thrombosis in everyday clinical practice through a multidisciplinary approach—the scientific programme covers a wide range of topics that is sure to interest anaesthesiologists, intensivists, surgeons, haematologists and transfusion medicine specialists. C ZECH R E P U B LI C on Patient Blood Management, Haemostasis and Thrombosis 16 th Annual NATA Symposium nata April 16-17 This year, notwithstanding our well-established areas of interest, special emphasis will be placed on evidence-based transfusion practice, optimal management of bleeding, and the role of iron therapy in patient blood management. I B lood Procurement and Transfusion Risks The scientific programme includes four practical workshops where a limited number of participants will be offered an excellent opportunity for clinical discussions and exchange of experience. The topics, carefully selected by the scientific committee for these interactive workshops, are: available technologies for cell salvage, management of massive bleeding, perioperative and emergency management of oral anticoagulants, and design and conduct of clinical trials in transfusion medicine. I Optimising the Practice of Transfusion I M anagement of the Bleeding Patient I T reatment of Anaemia and Iron Deficiency in Patient Blood Management I B urning Questions on Haemostasis and Thrombosis Finally, don’t miss out on our special, annual features: the best posters’ presentations and the late-breaking news session present upcoming and recently completed research. No doubt they will stir up a lot of discussion! I P ro/Con Debate: Using a Fixed RBC:FFP:PLT Ratio in Massively Bleeding Patients More than ever, the annual NATA symposium will provide a unique opportunity for stimulating and constructive exchanges across different specialties involved in patient blood management. I Best Posters I Breaking News I Workshops We look forward to meeting you in Prague for this outstanding event. Yours sincerely, Jean-François Hardy NATA Chair Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis www.nataonline.com THURSDAY, April 16, 2015 8:45-9:00 About NATA Welcome Address Jean-François Hardy, Montreal, QC, Canada LOOD PROCUREMENT AND TRANSFUSION RISKS B Rainer Moog, Berlin, Germany • Zdenka Gašová, Prague, Czech Republic 9:00-9:20 Optimal Management of Blood Donors Sant-Rayn Pasricha, Oxford, UK 9:20-9:40 Stem-Cell-Derived Blood Products: Present and Future Luc Douay, Paris, France The Network for the Advancement (No parallel session) Haemostasis and Thrombosis Transfusion-Related Immunomodulation: Yes, but What Does It Do to Our Patients? Jeffrey L. Carson, New Brunswick, NJ, USA 10:00-10:30 Questions and Answers (NATA) is unique in that it provides a 9:40-10:00 multidisciplinary forum for dialogue between haematologists, blood Break 10:30-11:00 bankers, anaesthesiologists, surgeons O PTIMISING THE PRACTICE OF TRANSFUSION > WORKSHOP > WORKSHOP Red Blood Cell Transfusion in Cardiac Surgery 11:00-11:20 Gavin Murphy, Leicester, UK MANAGEMENT OF MASSIVE BLEEDING MANAGEMENT OF PATIENTS ON ORAL ANTICOAGULANTS Real-Time Clinical Decision Support to Improve Blood Utilization 11:20-11:40 Lawrence Tim Goodnough, Stanford, CA, USA Sibylle A. Kozek-Langenecker, Vienna, Austria Charles-Marc Samama, Paris, France Methods to Implement Patient Blood Management 11:40-12:00 Kai Zacharowski, Frankfurt am Main, Germany Pär I. Johansson, Copenhagen, Denmark Marcel Levi, Amsterdam, The Netherlands Hans Gombotz, Linz, Austria • Karel Cvachovec, Prague, Czech Republic 12:00-12:30 Questions and Answers and other healthcare professionals interested in promoting best clinical practice in the fields of patient blood management, haemostasis and thrombosis. Recently, NATA’s mission statement—Promoting Lunch Break • Industry-Sponsored Satellite Symposia and Workshops 12:30-14:30 of Patient Blood Management, optimal patient blood management, M ANAGEMENT OF THE BLEEDING PATIENT > WORKSHOP > WORKSHOP haemostasis and thrombosis in Crystalloids vs. Starches vs. Albumin: the Never-Ending Question 14:30-14:50 Philippe Van der Linden, Brussels, Belgium HOW TO SET UP A CLINICAL TRIAL everyday clinical practice through Should We Be Using Fibrinogen Concentrate or Cryoprecipitate? 14:50-15:10 Jakob Stensballe, Copenhagen, Denmark Beverley J. Hunt, London, UK CELL SALVAGE FOR THE INEXPERIENCED—AN OVERVIEW OF THE AVAILABLE TECHNOLOGIES Pär I. Johansson, Copenhagen, Denmark • Vladimir Černý, Ústí nad Labem, Czech Republic Jeffrey L. Carson, New Brunswick, NJ, USA Antifibrinolytics to Reduce or Prevent Bleeding 15:10-15:30 Yves Ozier, Brest, France 15:30-16:00 Questions and Answers 16:00-16:30 Dafydd Thomas, Swansea, Wales, UK Jens Meier, Linz, Austria a multidisciplinary approach—was modified in order to better reflect the various clinical issues encountered in the management of anaemia, Break bleeding and thrombosis. BEST POSTERS’ PRESENTATION Charles-Marc Samama, Paris, France • Karel Cvachovec, Prague, Czech Republic Autologous Transfusion of Stored Red Blood Cells Increases Pulmonary Artery 16:30-16:45 Pressure Riccardo Pinciroli, Boston, MA, USA Impact of Individual Physician Blood Reports and 16:45-17:00 “1 vs. 2 Unit” Metric to Lower Red Blood Cell Transfusions Kathleen E. Puca, Milwaukee, WI, USA Cerebrovascular Response to Infusion of EAF P5K6-Alb, NO Producing, Colloidal Plasma Volume Expander, Is Muted in Transgenic Mouse Models of Sickle Cell 17:00-17:15 Disease Craig A. Branch, Bronx, NY, USA 17:15-17:30 Tranexamic Acid Reduces Transfusion Requirements in Adult Major Spine Surgery Jean-François Hardy, Montreal, QC, Canada 17:45-18:30 NATA General Assembly www.nataonline.com (No parallel session) Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis FRIDAY, April 17, 2015 ORGANIZING COMMITTEE BREAKING NEWS Chairs J.-F. Hardy, Montreal, QC, Canada Jean-François Hardy, Montreal, QC, Canada • Dafydd Thomas, Swansea, Wales, UK 8:40-9:00 Length of Red Blood Cell Storage and Clinical Outcomes in Transfused Critical Ill Adults— The Age of Blood Evaluation (ABLE) Randomised Controlled Trial Jacques Lacroix, Montreal, QC, Canada 9:00-9:20 Liberal Versus Restrictive Red Blood Cell Transfusion in ICU Patients with Septic Shock— The Transfusion Requirements in Septic Shock (TRISS) Trial Lars B. Holst, Copenhagen, Denmark 9:20-9:40 Long-Term Mortality in the Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS) Jeffrey L. Carson, New Brunswick, NJ, USA 9:40-10:00 Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: FIB-PPH Study Anne Wikkelsø, Copenhagen, Denmark (No parallel session) SCIENTIFIC COMMITTEE Chair C.-M. Samama, Paris, France 10:00-10:30 Questions and Answers Break 10:30-11:00 TREATMENT OF ANAEMIA AND IRON DEFICIENCY IN PATIENT BLOOD MANAGEMENT Manuel Muñoz, Málaga, Spain • Jaroslav Cermak, Prague, Czech Republic Anaemia Does Not Fatigue You; Functional Iron Deficiency Does 11:00-11:20 Lawrence Tim Goodnough, Stanford, CA, USA Management of Anaemia and Iron Deficiency in Pregnancy and in the Postpartum Period 11:20-11:40 Christian Breymann, Zurich, Switzerland Management of Anaemia and Iron Deficiency in Elective Surgical Patients 11:40-12:00 Elvira Bisbe, Barcelona, Spain > WORKSHOP > WORKSHOP HOW TO SET UP A CLINICAL TRIAL MANAGEMENT OF PATIENTS ON ORAL ANTICOAGULANTS Beverley J. Hunt, London, UK Charles-Marc Samama, Paris, France Jeffrey L. Carson, New Brunswick, NJ, USA David Faraoni, Brussels, Belgium 12:00-12:30 Questions and Answers 12:30-14:30 Lunch Break • Industry-Sponsored Satellite Symposia and Workshops BURNING QUESTIONS ON HAEMOSTASIS AND THROMBOSIS Charles-Marc Samama, Paris, France • Peter Salaj, Prague, Czech Republic Oral Anticoagulants: Update for 2015 14:30-14:50 Marcel Levi, Amsterdam, The Netherlands Specific and Non-Specific Reversal of Target-Specific Oral Anticoagulants 14:50-15:10 David Faraoni, Brussels, Belgium Viscoelastic Methods (TEG and ROTEM): Have We Progressed? 15:10-15:30 Beverley J. Hunt, London, UK > WORKSHOP > WORKSHOP MANAGEMENT OF MASSIVE BLEEDING CELL SALVAGE FOR THE INEXPERIENCED—AN OVERVIEW OF THE AVAILABLE TECHNOLOGIES Sibylle A. Kozek-Langenecker, Vienna, Austria Pär I. Johansson, Copenhagen, Denmark Dafydd Thomas, Swansea, Wales, UK Jens Meier, Linz, Austria 15:30-16:00 Questions and Answers PRO/CON DEBATE: USING A FIXED RBC:FFP:PLT RATIO IN MASSIVELY BLEEDING PATIENTS ^ Con: A 1:1:1 Ratio Is Useless 16:50-17:10 Sibylle A. Kozek-Langenecker, Vienna, Austria 17:10-17:30 Discussion Concluding Comments 17:30-17:45 Jean-François Hardy, Montreal, QC, Canada • Charles-Marc Samama, Paris, France -- Venue Registration/Information Jens Meier, Linz, Austria • Ivan Cundrle, Brno, Czech Republic Pro: A 1:1:1 Ratio Should Be Used Pär I. Johansson, Copenhagen, Denmark Members M. Auerbach, Baltimore, MD, USA E. Bisbe, Barcelona, Spain C. Breymann, Zurich, Switzerland J. L. Carson, New Brunswick, NJ, USA D. Faraoni, Brussels, Belgium D. A. Fergusson, Ottawa, ON, Canada T. Frietsch, Marburg, Germany J. A. García-Erce, Zaragoza, Spain A. Godier, Paris, France H. Gombotz, Linz, Austria L. T. Goodnough, Stanford, CA, USA O. Habler, Frankfurt, Germany E. Hansen, Regensburg, Germany B. J. Hunt, London, UK G. Inghilleri, Milan, Italy M. Intaglietta, La Jolla, CA, USA P. I. Johansson, Copenhagen, Denmark S. A. Kozek-Langenecker, Vienna, Austria J. Lacroix, Montreal, QC, Canada S. R. Leal-Noval, Seville, Spain M. Levi, Amsterdam, The Netherlands J. Meier, Linz, Austria R. Moog, Cottbus, Germany H. Morimatsu, Okayama, Japan M. Muñoz, Málaga, Spain H. V. New, London, UK Y. Ozier, Brest, France M. Piagnerelli, Charleroi, Belgium T. Richards, London, UK J. Stensballe, Copenhagen, Denmark D. Thomas, Swansea, Wales, UK A. G. Tsai, La Jolla, CA, USA C. E. Vagianos, Piraeus, Greece P. Van der Linden, Brussels, Belgium Prague Congress Centre 5. kvetna 65, 140 21 Prague 4 www.kcp.cz 16:00-16:30 Break 16:30-16:50 Members E. Bisbe, Barcelona, Spain H. Gombotz, Linz, Austria P. I. Johansson, Copenhagen, Denmark M. Levi, Amsterdam, The Netherlands J. Meier, Linz, Austria R. Moog, Cottbus, Germany M. Muñoz, Málaga, Spain C.-M. Samama, Paris, France D. Thomas, Swansea, Wales, UK (No parallel session) NATA c/o MedEd Global Solutions 27 rue Raffet, 75016 Paris, France Phone +33 142 536 009 Fax +33 141 103 667 E-mail: [email protected] Website : www.nataonline.com
© Copyright 2024